General Information of Drug (ID: DMNTQL5)

Drug Name
PMID28270010-Compound-Figure24-a Drug Info
Cross-matching ID
PubChem CID
11617559
ChEBI ID
CHEMBL261849
CAS Number
CAS 870483-87-7
TTD Drug ID
D0X9VS

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Rheumatoid arthritis 2.04 0.00e+0 78/93 (83.87%) CXCL8;CXCL2;VEGFA;...
Legionellosis 1.89 2.07e-2 51/57 (89.47%) CXCL8;CXCL2;CASP1;...
Antigen processing and presentation 1.83 2.48e-2 60/78 (76.92%) CTSS;CD74;HLA-DRA;...
Ubiquinone and other terpenoid-quinone biosynthesis 1.77 3.93e-2 9/11 (81.82%) HPD;VKORC1;COQ2;...
Caffeine metabolism 1.76 3.14e-2 5/6 (83.33%) NAT1;CYP2A6;NAT2;...
Endocrine and other factor-regulated calcium reabsorpti... -1.76 4.48e-2 49/53 (92.45%) ATP1B3;CLTCL1;ATP2B4;...
Carbohydrate digestion and absorption -1.79 3.62e-2 37/47 (78.72%) ATP1A2;HK1;AKT3;...
Glycerolipid metabolism -1.80 4.34e-2 44/61 (72.13%) LIPF;DGKZ;DGAT1;...
Type II diabetes mellitus -1.89 2.41e-2 42/46 (91.3%) HK1;IKBKB;SOCS1;...
Insulin secretion -1.92 1.21e-2 75/86 (87.21%) PLCB4;ATP1A3;CACNA1D;...
Phosphatidylinositol signaling system -2.06 1.21e-2 82/97 (84.54%) PIK3CB;IP6K1;PLCG1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 1.11uM - 10uM 24H